Ansell Ltd
Company Profile
Business description
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 55% of revenue and 50% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents, and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2025, Ansell earned 46% of revenue in North America, 31% from Europe, Middle East, and Africa, 14% across Asia-Pacific, and the remaining 10% in Latin America.
Contact
678 Victoria Street
Level 3
Richmond
MelbourneVIC3121
AUST: +61 392707222
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 June 2026
Employees
15,724
Ansell Ltd News & Analysis
stocks
ASX results reaction: WiseTech, Woolies, Sigma and more
stocks
ASX healthcare stocks shrug off new tariff threat
stocks
3 cheap ASX shares with sound balance sheets
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,887.60 | 9.10 | 0.10% |
| CAC 40 | 8,173.11 | 85.15 | -1.03% |
| DAX 40 | 25,184.89 | 204.21 | -0.80% |
| Dow JONES (US) | 50,461.68 | 118.02 | -0.23% |
| FTSE 100 | 10,491.39 | 25.13 | 0.24% |
| HKSE | 25,559.09 | 40.36 | -0.16% |
| NASDAQ | 26,656.18 | 312.21 | 1.19% |
| Nikkei 225 | 65,615.50 | 619.41 | 0.95% |
| NZX 50 Index | 13,162.43 | 92.69 | 0.71% |
| S&P 500 | 7,519.12 | 45.65 | 0.61% |
| S&P/ASX 200 | 8,655.70 | 3.50 | 0.04% |
| SSE Composite Index | 4,136.50 | 8.88 | -0.21% |